G217-0154 Screening compound: N-(4-{[3-(2-ethylpiperidin-1-yl)propyl]carbamoyl}phenyl)-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carboxamide

G217-0154 Screening compound: N-(4-{[3-(2-ethylpiperidin-1-yl)propyl]carbamoyl}phenyl)-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carboxamide
G217-0154 Screening compound: N-(4-{[3-(2-ethylpiperidin-1-yl)propyl]carbamoyl}phenyl)-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G217-0154
N-(4-{[3-(2-ethylpiperidin-1-yl)propyl]carbamoyl}phenyl)-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G217-0154

Molecular Formula

C28H38N4O2 (C28 H38 N4 O2)

Compound Name

N-(4-{[3-(2-ethylpiperidin-1-yl)propyl]carbamoyl}phenyl)-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carboxamide

IUPAC name

N-(4-{[3-(2-ethylpiperidin-1-yl)propyl]carbamoyl}phenyl)-2345-tetrahydro-1H-1-benzazepine-1-carboxamide

SMILES

CCC1N(CCCNC(c(cc2)ccc2NC(N(CCCC2)c3c2cccc3)=O)=O)CCCC1

InChI

InChI=1S/C28H38N4O2/c1-2-25-12-6-7-19-31(25)20-9-18-29-27(33)23-14-16-24(17-15-23)30-28(34)32-21-8-5-11-22-10-3-4-13-26(22)32/h3-4,10,13-17,25H,2,5-9,11-12,18-21H2,1H3,(H,29,33)(H,30,34)/t25-/m0/s1

InChI Key

PIOLVHCWQGJORN-VWLOTQADSA-N

MDL Number (MFCD)

MFCD14987331

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

462.64

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.880

Distribution Coefficient, logD

2.013

Water Solubility, LogSw

-4.40

Polar Surface Area

52.752

Acid Dissociation Constant (pKa)

11.11

Base Dissociation Constant (pKb)

10.27

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

50.00

G217-0154 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anti-Inflammatory Library (24602 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Protein-Protein Interaction Library (218420 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Nervous system
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with G217-0154 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G217-0154?
Check Price and Availability of G217-0154, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G217-0154 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G217-0154
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G217-0154
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G217-0154 available by request